Pre-order Enquiry
Request Free Sample
Global Primary Hyperoxaluria Treatment Market Research Report 2023
SKU ID : QYR-23554775 | Publishing Date : 20-Apr-2023
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Primary Hyperoxaluria Treatment Market Research Report 2023
1 Primary Hyperoxaluria Treatment Market Overview1.1 Product Overview and Scope of Primary Hyperoxaluria Treatment
1.2 Primary Hyperoxaluria Treatment Segment by Type
1.2.1 Global Primary Hyperoxaluria Treatment Market Value Comparison by Type (2023-2029)
1.2.2 Oral
1.2.3 Intravenous
1.2.4 Others
1.3 Primary Hyperoxaluria Treatment Segment by Application
1.3.1 Global Primary Hyperoxaluria Treatment Market Value by Application: (2023-2029)
1.3.2 Type 1
1.3.3 Type 2
1.3.4 Type 3
1.4 Global Primary Hyperoxaluria Treatment Market Size Estimates and Forecasts
1.4.1 Global Primary Hyperoxaluria Treatment Revenue 2018-2029
1.4.2 Global Primary Hyperoxaluria Treatment Sales 2018-2029
1.4.3 Global Primary Hyperoxaluria Treatment Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Primary Hyperoxaluria Treatment Market Competition by Manufacturers
2.1 Global Primary Hyperoxaluria Treatment Sales Market Share by Manufacturers (2018-2023)
2.2 Global Primary Hyperoxaluria Treatment Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Primary Hyperoxaluria Treatment Average Price by Manufacturers (2018-2023)
2.4 Global Primary Hyperoxaluria Treatment Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Primary Hyperoxaluria Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Primary Hyperoxaluria Treatment, Product Type & Application
2.7 Primary Hyperoxaluria Treatment Market Competitive Situation and Trends
2.7.1 Primary Hyperoxaluria Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Primary Hyperoxaluria Treatment Players Market Share by Revenue
2.7.3 Global Primary Hyperoxaluria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Primary Hyperoxaluria Treatment Retrospective Market Scenario by Region
3.1 Global Primary Hyperoxaluria Treatment Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Primary Hyperoxaluria Treatment Global Primary Hyperoxaluria Treatment Sales by Region: 2018-2029
3.2.1 Global Primary Hyperoxaluria Treatment Sales by Region: 2018-2023
3.2.2 Global Primary Hyperoxaluria Treatment Sales by Region: 2024-2029
3.3 Global Primary Hyperoxaluria Treatment Global Primary Hyperoxaluria Treatment Revenue by Region: 2018-2029
3.3.1 Global Primary Hyperoxaluria Treatment Revenue by Region: 2018-2023
3.3.2 Global Primary Hyperoxaluria Treatment Revenue by Region: 2024-2029
3.4 North America Primary Hyperoxaluria Treatment Market Facts & Figures by Country
3.4.1 North America Primary Hyperoxaluria Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Primary Hyperoxaluria Treatment Sales by Country (2018-2029)
3.4.3 North America Primary Hyperoxaluria Treatment Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Primary Hyperoxaluria Treatment Market Facts & Figures by Country
3.5.1 Europe Primary Hyperoxaluria Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Primary Hyperoxaluria Treatment Sales by Country (2018-2029)
3.5.3 Europe Primary Hyperoxaluria Treatment Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Primary Hyperoxaluria Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Primary Hyperoxaluria Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Primary Hyperoxaluria Treatment Sales by Country (2018-2029)
3.6.3 Asia Pacific Primary Hyperoxaluria Treatment Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Primary Hyperoxaluria Treatment Market Facts & Figures by Country
3.7.1 Latin America Primary Hyperoxaluria Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Primary Hyperoxaluria Treatment Sales by Country (2018-2029)
3.7.3 Latin America Primary Hyperoxaluria Treatment Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Primary Hyperoxaluria Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Primary Hyperoxaluria Treatment Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Primary Hyperoxaluria Treatment Sales by Country (2018-2029)
3.8.3 Middle East and Africa Primary Hyperoxaluria Treatment Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Primary Hyperoxaluria Treatment Sales by Type (2018-2029)
4.1.1 Global Primary Hyperoxaluria Treatment Sales by Type (2018-2023)
4.1.2 Global Primary Hyperoxaluria Treatment Sales by Type (2024-2029)
4.1.3 Global Primary Hyperoxaluria Treatment Sales Market Share by Type (2018-2029)
4.2 Global Primary Hyperoxaluria Treatment Revenue by Type (2018-2029)
4.2.1 Global Primary Hyperoxaluria Treatment Revenue by Type (2018-2023)
4.2.2 Global Primary Hyperoxaluria Treatment Revenue by Type (2024-2029)
4.2.3 Global Primary Hyperoxaluria Treatment Revenue Market Share by Type (2018-2029)
4.3 Global Primary Hyperoxaluria Treatment Price by Type (2018-2029)
5 Segment by Application
5.1 Global Primary Hyperoxaluria Treatment Sales by Application (2018-2029)
5.1.1 Global Primary Hyperoxaluria Treatment Sales by Application (2018-2023)
5.1.2 Global Primary Hyperoxaluria Treatment Sales by Application (2024-2029)
5.1.3 Global Primary Hyperoxaluria Treatment Sales Market Share by Application (2018-2029)
5.2 Global Primary Hyperoxaluria Treatment Revenue by Application (2018-2029)
5.2.1 Global Primary Hyperoxaluria Treatment Revenue by Application (2018-2023)
5.2.2 Global Primary Hyperoxaluria Treatment Revenue by Application (2024-2029)
5.2.3 Global Primary Hyperoxaluria Treatment Revenue Market Share by Application (2018-2029)
5.3 Global Primary Hyperoxaluria Treatment Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Oxthera
6.1.1 Oxthera Corporation Information
6.1.2 Oxthera Description and Business Overview
6.1.3 Oxthera Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Oxthera Primary Hyperoxaluria Treatment Product Portfolio
6.1.5 Oxthera Recent Developments/Updates
6.2 Dicerna Pharmaceuticals
6.2.1 Dicerna Pharmaceuticals Corporation Information
6.2.2 Dicerna Pharmaceuticals Description and Business Overview
6.2.3 Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Product Portfolio
6.2.5 Dicerna Pharmaceuticals Recent Developments/Updates
6.3 Allena Pharmaceuticals
6.3.1 Allena Pharmaceuticals Corporation Information
6.3.2 Allena Pharmaceuticals Description and Business Overview
6.3.3 Allena Pharmaceuticals Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Allena Pharmaceuticals Primary Hyperoxaluria Treatment Product Portfolio
6.3.5 Allena Pharmaceuticals Recent Developments/Updates
6.4 Biocodex
6.4.1 Biocodex Corporation Information
6.4.2 Biocodex Description and Business Overview
6.4.3 Biocodex Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Biocodex Primary Hyperoxaluria Treatment Product Portfolio
6.4.5 Biocodex Recent Developments/Updates
6.5 Alnylam Pharmaceuticals
6.5.1 Alnylam Pharmaceuticals Corporation Information
6.5.2 Alnylam Pharmaceuticals Description and Business Overview
6.5.3 Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Product Portfolio
6.5.5 Alnylam Pharmaceuticals Recent Developments/Updates
6.6 Tecoland Corporation
6.6.1 Tecoland Corporation Corporation Information
6.6.2 Tecoland Corporation Description and Business Overview
6.6.3 Tecoland Corporation Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Tecoland Corporation Primary Hyperoxaluria Treatment Product Portfolio
6.6.5 Tecoland Corporation Recent Developments/Updates
6.7 Zhejiang Tianxin Pharmaceutical
6.6.1 Zhejiang Tianxin Pharmaceutical Corporation Information
6.6.2 Zhejiang Tianxin Pharmaceutical Description and Business Overview
6.6.3 Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Product Portfolio
6.7.5 Zhejiang Tianxin Pharmaceutical Recent Developments/Updates
6.8 Takeda Pharmaceuticals
6.8.1 Takeda Pharmaceuticals Corporation Information
6.8.2 Takeda Pharmaceuticals Description and Business Overview
6.8.3 Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Product Portfolio
6.8.5 Takeda Pharmaceuticals Recent Developments/Updates
6.9 Wuxi Further Pharmaceutical
6.9.1 Wuxi Further Pharmaceutical Corporation Information
6.9.2 Wuxi Further Pharmaceutical Description and Business Overview
6.9.3 Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Product Portfolio
6.9.5 Wuxi Further Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Primary Hyperoxaluria Treatment Industry Chain Analysis
7.2 Primary Hyperoxaluria Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Primary Hyperoxaluria Treatment Production Mode & Process
7.4 Primary Hyperoxaluria Treatment Sales and Marketing
7.4.1 Primary Hyperoxaluria Treatment Sales Channels
7.4.2 Primary Hyperoxaluria Treatment Distributors
7.5 Primary Hyperoxaluria Treatment Customers
8 Primary Hyperoxaluria Treatment Market Dynamics
8.1 Primary Hyperoxaluria Treatment Industry Trends
8.2 Primary Hyperoxaluria Treatment Market Drivers
8.3 Primary Hyperoxaluria Treatment Market Challenges
8.4 Primary Hyperoxaluria Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Figures, Tables and Charts Available in Global Primary Hyperoxaluria Treatment Market Research Report 2023
List of TablesTable 1. Global Primary Hyperoxaluria Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Primary Hyperoxaluria Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Primary Hyperoxaluria Treatment Market Competitive Situation by Manufacturers in 2022
Table 4. Global Primary Hyperoxaluria Treatment Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Primary Hyperoxaluria Treatment Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Primary Hyperoxaluria Treatment Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Primary Hyperoxaluria Treatment Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Primary Hyperoxaluria Treatment Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Primary Hyperoxaluria Treatment, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Primary Hyperoxaluria Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Primary Hyperoxaluria Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Primary Hyperoxaluria Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Primary Hyperoxaluria Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Hyperoxaluria Treatment as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Primary Hyperoxaluria Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Primary Hyperoxaluria Treatment Sales by Region (2018-2023) & (K Units)
Table 18. Global Primary Hyperoxaluria Treatment Sales Market Share by Region (2018-2023)
Table 19. Global Primary Hyperoxaluria Treatment Sales by Region (2024-2029) & (K Units)
Table 20. Global Primary Hyperoxaluria Treatment Sales Market Share by Region (2024-2029)
Table 21. Global Primary Hyperoxaluria Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Primary Hyperoxaluria Treatment Revenue Market Share by Region (2018-2023)
Table 23. Global Primary Hyperoxaluria Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Primary Hyperoxaluria Treatment Revenue Market Share by Region (2024-2029)
Table 25. North America Primary Hyperoxaluria Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Primary Hyperoxaluria Treatment Sales by Country (2018-2023) & (K Units)
Table 27. North America Primary Hyperoxaluria Treatment Sales by Country (2024-2029) & (K Units)
Table 28. North America Primary Hyperoxaluria Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Primary Hyperoxaluria Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Primary Hyperoxaluria Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Primary Hyperoxaluria Treatment Sales by Country (2018-2023) & (K Units)
Table 32. Europe Primary Hyperoxaluria Treatment Sales by Country (2024-2029) & (K Units)
Table 33. Europe Primary Hyperoxaluria Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Primary Hyperoxaluria Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Primary Hyperoxaluria Treatment Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Primary Hyperoxaluria Treatment Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Primary Hyperoxaluria Treatment Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Primary Hyperoxaluria Treatment Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Primary Hyperoxaluria Treatment Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Primary Hyperoxaluria Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Primary Hyperoxaluria Treatment Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Primary Hyperoxaluria Treatment Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Primary Hyperoxaluria Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Primary Hyperoxaluria Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Primary Hyperoxaluria Treatment Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Primary Hyperoxaluria Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Primary Hyperoxaluria Treatment Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Primary Hyperoxaluria Treatment Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Primary Hyperoxaluria Treatment Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Primary Hyperoxaluria Treatment Sales (K Units) by Type (2018-2023)
Table 51. Global Primary Hyperoxaluria Treatment Sales (K Units) by Type (2024-2029)
Table 52. Global Primary Hyperoxaluria Treatment Sales Market Share by Type (2018-2023)
Table 53. Global Primary Hyperoxaluria Treatment Sales Market Share by Type (2024-2029)
Table 54. Global Primary Hyperoxaluria Treatment Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Primary Hyperoxaluria Treatment Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Primary Hyperoxaluria Treatment Revenue Market Share by Type (2018-2023)
Table 57. Global Primary Hyperoxaluria Treatment Revenue Market Share by Type (2024-2029)
Table 58. Global Primary Hyperoxaluria Treatment Price (US$/Unit) by Type (2018-2023)
Table 59. Global Primary Hyperoxaluria Treatment Price (US$/Unit) by Type (2024-2029)
Table 60. Global Primary Hyperoxaluria Treatment Sales (K Units) by Application (2018-2023)
Table 61. Global Primary Hyperoxaluria Treatment Sales (K Units) by Application (2024-2029)
Table 62. Global Primary Hyperoxaluria Treatment Sales Market Share by Application (2018-2023)
Table 63. Global Primary Hyperoxaluria Treatment Sales Market Share by Application (2024-2029)
Table 64. Global Primary Hyperoxaluria Treatment Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Primary Hyperoxaluria Treatment Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Primary Hyperoxaluria Treatment Revenue Market Share by Application (2018-2023)
Table 67. Global Primary Hyperoxaluria Treatment Revenue Market Share by Application (2024-2029)
Table 68. Global Primary Hyperoxaluria Treatment Price (US$/Unit) by Application (2018-2023)
Table 69. Global Primary Hyperoxaluria Treatment Price (US$/Unit) by Application (2024-2029)
Table 70. Oxthera Corporation Information
Table 71. Oxthera Description and Business Overview
Table 72. Oxthera Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Oxthera Primary Hyperoxaluria Treatment Product
Table 74. Oxthera Recent Developments/Updates
Table 75. Dicerna Pharmaceuticals Corporation Information
Table 76. Dicerna Pharmaceuticals Description and Business Overview
Table 77. Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Dicerna Pharmaceuticals Primary Hyperoxaluria Treatment Product
Table 79. Dicerna Pharmaceuticals Recent Developments/Updates
Table 80. Allena Pharmaceuticals Corporation Information
Table 81. Allena Pharmaceuticals Description and Business Overview
Table 82. Allena Pharmaceuticals Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Allena Pharmaceuticals Primary Hyperoxaluria Treatment Product
Table 84. Allena Pharmaceuticals Recent Developments/Updates
Table 85. Biocodex Corporation Information
Table 86. Biocodex Description and Business Overview
Table 87. Biocodex Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Biocodex Primary Hyperoxaluria Treatment Product
Table 89. Biocodex Recent Developments/Updates
Table 90. Alnylam Pharmaceuticals Corporation Information
Table 91. Alnylam Pharmaceuticals Description and Business Overview
Table 92. Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Alnylam Pharmaceuticals Primary Hyperoxaluria Treatment Product
Table 94. Alnylam Pharmaceuticals Recent Developments/Updates
Table 95. Tecoland Corporation Corporation Information
Table 96. Tecoland Corporation Description and Business Overview
Table 97. Tecoland Corporation Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Tecoland Corporation Primary Hyperoxaluria Treatment Product
Table 99. Tecoland Corporation Recent Developments/Updates
Table 100. Zhejiang Tianxin Pharmaceutical Corporation Information
Table 101. Zhejiang Tianxin Pharmaceutical Description and Business Overview
Table 102. Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Zhejiang Tianxin Pharmaceutical Primary Hyperoxaluria Treatment Product
Table 104. Zhejiang Tianxin Pharmaceutical Recent Developments/Updates
Table 105. Takeda Pharmaceuticals Corporation Information
Table 106. Takeda Pharmaceuticals Description and Business Overview
Table 107. Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Takeda Pharmaceuticals Primary Hyperoxaluria Treatment Product
Table 109. Takeda Pharmaceuticals Recent Developments/Updates
Table 110. Wuxi Further Pharmaceutical Corporation Information
Table 111. Wuxi Further Pharmaceutical Description and Business Overview
Table 112. Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Wuxi Further Pharmaceutical Primary Hyperoxaluria Treatment Product
Table 114. Wuxi Further Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Primary Hyperoxaluria Treatment Distributors List
Table 118. Primary Hyperoxaluria Treatment Customers List
Table 119. Primary Hyperoxaluria Treatment Market Trends
Table 120. Primary Hyperoxaluria Treatment Market Drivers
Table 121. Primary Hyperoxaluria Treatment Market Challenges
Table 122. Primary Hyperoxaluria Treatment Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Primary Hyperoxaluria Treatment
Figure 2. Global Primary Hyperoxaluria Treatment Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Primary Hyperoxaluria Treatment Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Intravenous Product Picture
Figure 6. Others Product Picture
Figure 7. Global Primary Hyperoxaluria Treatment Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Primary Hyperoxaluria Treatment Market Share by Application in 2022 & 2029
Figure 9. Type 1
Figure 10. Type 2
Figure 11. Type 3
Figure 12. Global Primary Hyperoxaluria Treatment Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Primary Hyperoxaluria Treatment Market Size (2018-2029) & (US$ Million)
Figure 14. Global Primary Hyperoxaluria Treatment Sales (2018-2029) & (K Units)
Figure 15. Global Primary Hyperoxaluria Treatment Average Price (US$/Unit) & (2018-2029)
Figure 16. Primary Hyperoxaluria Treatment Report Years Considered
Figure 17. Primary Hyperoxaluria Treatment Sales Share by Manufacturers in 2022
Figure 18. Global Primary Hyperoxaluria Treatment Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Primary Hyperoxaluria Treatment Players: Market Share by Revenue in 2022
Figure 20. Primary Hyperoxaluria Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Primary Hyperoxaluria Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Primary Hyperoxaluria Treatment Sales Market Share by Country (2018-2029)
Figure 23. North America Primary Hyperoxaluria Treatment Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Primary Hyperoxaluria Treatment Sales Market Share by Country (2018-2029)
Figure 27. Europe Primary Hyperoxaluria Treatment Revenue Market Share by Country (2018-2029)
Figure 28. Germany Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Primary Hyperoxaluria Treatment Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Primary Hyperoxaluria Treatment Revenue Market Share by Region (2018-2029)
Figure 35. China Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Primary Hyperoxaluria Treatment Sales Market Share by Country (2018-2029)
Figure 46. Latin America Primary Hyperoxaluria Treatment Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Primary Hyperoxaluria Treatment Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Primary Hyperoxaluria Treatment Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Primary Hyperoxaluria Treatment Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Primary Hyperoxaluria Treatment by Type (2018-2029)
Figure 56. Global Revenue Market Share of Primary Hyperoxaluria Treatment by Type (2018-2029)
Figure 57. Global Primary Hyperoxaluria Treatment Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Primary Hyperoxaluria Treatment by Application (2018-2029)
Figure 59. Global Revenue Market Share of Primary Hyperoxaluria Treatment by Application (2018-2029)
Figure 60. Global Primary Hyperoxaluria Treatment Price (US$/Unit) by Application (2018-2029)
Figure 61. Primary Hyperoxaluria Treatment Value Chain
Figure 62. Primary Hyperoxaluria Treatment Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Keyplayers in Global Primary Hyperoxaluria Treatment Market Research Report 2023
OxtheraDicerna Pharmaceuticals
Allena Pharmaceuticals
Biocodex
Alnylam Pharmaceuticals
Tecoland Corporation
Zhejiang Tianxin Pharmaceutical
Takeda Pharmaceuticals
Wuxi Further Pharmaceutical
